MP
NVO

Manifold Partners’s Novo Nordisk NVO Stock Holding History

Manifold Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-20,740
Closed -$602K – 77
2015
Q4 		$602K Hold
20,740
– – 0.53% 21
2015
Q3 		$562K Buy
+20,740
New +$587K 0.52% 22

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Manifold Partners's NVO Position: Q1 2016 in Review

Manifold Partners sold out of Novo Nordisk (NVO) in Q1 2016, closing a stake of 20,740 shares — an estimated $602K sold.

Manifold Partners first reported a position in NVO in Q3 2015 and held it in 2 quarters. The position peaked at $602K in Q4 2015. 536 funds tracked by Wall St. Rank hold NVO as of Q1 2016.

  • Manifold Partners reported no remaining Novo Nordisk position as of Q1 2016 after selling out during the quarter.
  • Manifold Partners sold 20,740 Novo Nordisk shares in Q1 2016, an estimated $602K.
  • Manifold Partners first reported a position in Novo Nordisk in Q3 2015 and held it in 2 quarters.
  • Manifold Partners's Novo Nordisk position peaked at $602K in Q4 2015.
  • 536 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2016.

Based on Manifold Partners's 13F filing for Q1 2016, filed 2 Jun 2016.